Call for Challenges for the 2025 N-CODE Study Group! Deadline 29th Jan
We invite stakeholders (industry, clinicians, charities) to propose challenges of unmet need in #neurotech that could be addressed by collaborative research at the 2025 Study Group
https://t.co/3ifT1UDrH8
📢Job opportunity! 2 year Research Fellow (G7) role working with @JT_Running to develop & apply mathematical models and computational algorithms to understand how perturbations to dynamic brain networks impact upon seizure likelihood in epilepsy.
https://t.co/OMj1Tn9Ph1
Welcome to Louis Gall! We are pleased to welcome Louis to SMQB as a Centre Fellow. He has an interest in agent-based modelling, quantitative systems pharmacology/toxicology (QSP/T) and mathematical modelling of intracellular protein networks (e.g. circadian clock and cell cycle).
📢Sign up now for our free online event about Public Engagement in Computer Science! Join us for insightful discussions, workshops and training, with speakers from @EPSRC, @unibirmingham & @turinginst. Register now to secure your spot! https://t.co/crnQcYcrPm #compsci
Huge congrats to Bristol-based @Neuronostics for winning $125K at the 2024 Epilepsy Foundation Shark Tank! Their BioEP™ tool revolutionises epilepsy diagnosis using EEG data. Next stop: NHS in 2025 and the US market in 2026 > https://t.co/1dNoJTXC59 #MedTech#Innovation#Bristol
Epilepsy researchers! Register now for this @EpilepsyInst Navigator Symposium in partnership with the @ncode_network on Data Science & Translation in #epilepsy. 3rd October, London. Chaired by SMQB's @wessel_woldman, ERI Emerging Leader Fellow. Keynote talk from @ViktorJirsa
Another impactful publication from @SMQB_UoB! Great work from @Le_Junges@D_E_Galvis@AndrewBagshaw4 and others.
#PLOSONE: The impact of paediatric epilepsy and co-occurring neurodevelopmental disorders on functional brain ... https://t.co/PAQf2U80Rv
And Founder of the Year goes to… John Terry at @neuronostics#TheSPARKies2024 🙌
The judges highlighted that John has been a driving force for Neuronostics. Despite a challenging environment for funding John pulled together an oversubscribed seed round over £2M
Well done to Gwen and Peter for their first published work. A really nice study explore dynamic mechanisms underpinning variation in treatment response in epilepsy over time https://t.co/9Vg99Ki3Up